Cost-Effectiveness of Blood-Based Brain Biomarkers for Screening Adults with Mild Traumatic Brain Injury in the French Health Care Setting

Two blood-based brain biomarker tests such as the combination of glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 (GFAP+UCH-L1) or S100B have potential to reduce the need for head computed tomography (CT) scanning in patients with mild traumatic brain injury (mTBI). We assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmer, Louise, McDade, Cheryl, Beyhaghi, Hadi, Purser, Molly, Textoris, Julien, Krause, Alexander, Blanc, Esther, Pavlov, Vladislav, Earnshaw, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061334/
https://www.ncbi.nlm.nih.gov/pubmed/36267001
http://dx.doi.org/10.1089/neu.2022.0270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061334/
https://www.ncbi.nlm.nih.gov/pubmed/36267001
http://dx.doi.org/10.1089/neu.2022.0270

Ejemplares similares